TY - JOUR T1 - Workplace Infection Prevention Control Measures and Work Engagement During the COVID-19 Pandemic among Japanese Workers: A Prospective Cohort Study JF - medRxiv DO - 10.1101/2022.04.11.22273753 SP - 2022.04.11.22273753 AU - Kazunori Ikegami AU - Hajime Ando AU - Yoshihisa Fujino AU - Hisashi Eguchi AU - Keiji Muramatsu AU - Tomohisa Nagata AU - Seiichiro Tateishi AU - Mayumi Tsuji AU - Akira Ogami AU - the CORoNaWork project Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/04/12/2022.04.11.22273753.abstract N2 - Objectives It has been widely reported that the COVID-19 pandemic may have a psychological influence on people. Thus, it could be important to note how workplace infection prevention and control (IPC) measures for COVID-19 contribute to positive mental health among workers. We hypothesized that if workplace IPC measures are adequately implemented, they would have a positive effect on employees’ work engagement.Methods We conducted an internet-based prospective cohort study from December 2020 (baseline) to December 2021 (follow-up after one year) using self-administered questionnaires. At baseline, 27,036 workers completed the questionnaires, while 18,560 (68.7%) participated in the one-year follow-up. After excluding the 6,578 participants who changed jobs or retired during the survey period, or telecommuted more than four days per week, 11,982 participants were analyzed. We asked participants about the implementation of workplace IPC measures at baseline and conducted a nine-item version of the Utrecht Work Engagement Scale (UWES-9) at follow-up.Results Four groups were created according to the number of workplace IPC measures implemented. The mean (SD) UWES-9 score of the “0–2” group was the lowest at 18.3 (13.2), while that of the “8” group was the highest at 22.6 (12.6). The scores of the “3– 5,” “6–7,” and “8” groups were significantly higher than that of the “0–2” group (all, p<0.001). The p trend of the four groups was also significant (p<0.001).Conclusions Promoting workplace IPC measures improves workers’ work engagement, and a dose-response relationship exists between workplace IPC measures and work engagement.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported and partly funded by the research grant from the University of Occupational and Environmental Health, Japan (no grant number); Japanese Ministry of Health, Labour and Welfare (H30-josei-ippan-002, H30-roudou-ippan-007, 19JA1004, 20JA1006, 210301-1, and 20HB1004); Anshin Zaidan (no grant number), the Collabo-Health Study Group (no grant number), and Hitachi Systems, Ltd. (no grant number) and scholarship donations from Chugai Pharmaceutical Co., Ltd. (no grant number). The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of the University of Occupational and Environmental Health, Japan gave ethical approval for this work(Reference No. R2-079 and R3-006).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the study are available upon reasonable request to the authors. ER -